Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
about
Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivoAnti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in MiceBiotinylation of K12 in histone H4 decreases in response to DNA double-strand breaks in human JAr choriocarcinoma cellsIron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells.A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis.Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia.Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.The Novel Triazolonaphthalimide Derivative LSS-11 Synergizes the Anti-Proliferative Effect of Paclitaxel via STAT3-Dependent MDR1 and MRP1 Downregulation in Chemoresistant Lung Cancer Cells.
P2860
Q24792079-7029BC39-57EA-4207-A3DB-4871531A68B2Q24815007-33C9F085-53E0-4DFC-890D-75DFBA91BC34Q27345163-725CC9C8-9D78-4568-83CE-A294CD6533C9Q34093042-BC552DC7-99C4-41E7-BB9A-818FA778E071Q34571662-F59F1973-1689-4F64-978F-9715A472FE61Q35862550-561A1B45-7F73-4FF4-B1F2-8DBEC7534D24Q35868560-CAF46E94-88E0-4C05-AEE1-18F58749486BQ35930414-4EB917A3-AC3D-4698-BCD2-8CC30D624C19Q38809957-C2A48EEA-B4E7-42C7-A5F3-06D022B4CF25Q47129596-85EAABA8-4829-42E1-B6AB-E90898153EACQ47601279-1523D7C7-298A-4E39-9C68-7A8A7A3B3C6D
P2860
Dexrazoxane significantly impairs the induction of doxorubicin resistance in the human leukaemia line, K562
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@ast
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@en
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@nl
type
label
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@ast
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@en
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@nl
prefLabel
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@ast
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@en
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@nl
P2093
P2860
P356
P1476
Dexrazoxane significantly impa ...... the human leukaemia line, K562
@en
P2093
C G Taylor
C J Williamson
J M Sargent
K Hellmann
P2860
P2888
P304
P356
10.1054/BJOC.2001.1697
P407
P577
2001-04-06T00:00:00Z
P5875
P6179
1019687357